Biotechs are now almost fully digital, but they're using multiple pieces of software to accomplish their drug discovery goals. It's understandable, people like what they like. Though, as a company, decisions should made to benefit the whole. Why not deliver on that? Revvity Signals is delivering on a longstanding desire within this space. An agnostic, one-suite-fits-all, platform that covers the entirety of your drug discovery workflow. No stones were left unturned in the development of this suite. Our customers know this & we're incredibly excited to continue delivering on the model that makes Revvity Signals run. Here's just one of the newest features added to the Revvity Signals Suite. Our Sponsor to Contractor (CRO, CMO, CDMO) solution.
John Giese’s Post
More Relevant Posts
-
Recorded Webinar...How Octant is using both Collaborative Drug Discovery - CDD Vault and Torx® Software to transform drug discovery? https://lnkd.in/gwukxsyy
-
Complex challenges call for a nimble approach. And, because every clinical trial looks different, every LabConnect solution looks different. Need to hit an exceedingly tight timeline? Or fast-track custom collection kits? Learn how our nimble approach can help accelerate your drug development milestones. Download the case study today => https://lnkd.in/g9fr2D7K #LabConnect #CaseStudy #ClinicalTrial #Nimble
-
-
BlueAllele can proceed with its patent infringement case against Intellia Therapeutics after a Delaware judge rejected Intellia’s attempt to dismiss the suit using the Hatch-Waxman Act’s safe harbor defense. The Minnesota biotech accuses Intellia of infringing its patented gene-editing technology, alleging the rival secured over $100 million from Regeneron for its use in developing therapeutic candidates. Read the full story here: https://ow.ly/C3M350UoVjn #Biotech #PatentLaw #GeneEditing
Judge denies Intellia bid to throw out suit over $100m Regeneron pact
lifesciencesipreview.com
-
SPEED, FLEXIBILITY, PRECISION : Vital attributes of a #CentralLab partner for every #ClinicalTrial sponsor - and hallmarks of MLM Medical Labs. From industry leading study startup times to fully customizable testing solutions to rapid rescue protocols, MLM brings efficiencies and expertise to every phase of the drug development process. Learn more about our Central Lab services and protect two of your research team's most valuable assets : time and money. #clinicaltrials #assaydevelopment #biomarkers #safetylabtesting #specialtytesting
-
-
At Flowtrial, we champion a holistic approach to clinical trials. Why? Because understanding the complete landscape is key to success. ✨ Holistic Oversight Means: • Clarity: Seeing beyond immediate tasks for better insights. • Proactivity: Foreseeing obstacles, crafting early solutions. • Cohesiveness: Ensuring that each aspect of the trial synergizes with others. Our holistic method ensures every phase of your trial is interconnected and optimized for success. Ready to see your clinical trials thrive with a holistic strategy? Let’s connect! #Flowtrial #ClinicalTrials #HolisticApproach #Innovation #RiskManagement #Pharma #SponsorOversight #GCP #clinicalresearch #clinicaloversight
-
-
Accelerate your drug development milestones with LabConnect 💊
Complex challenges call for a nimble approach. And, because every clinical trial looks different, every LabConnect solution looks different. Need to hit an exceedingly tight timeline? Or fast-track custom collection kits? Learn how our nimble approach can help accelerate your drug development milestones. Download the case study today => https://lnkd.in/g9fr2D7K #LabConnect #CaseStudy #ClinicalTrial #Nimble
-
-
#LabConnect #CaseStudy #ClinicalTrial #Nimble Complex challenges call for a nimble approach. And, because every clinical trial looks different, every LabConnect solution looks different. Need to hit an exceedingly tight timeline? Or fast-track custom collection kits? Learn how our nimble approach can help accelerate your drug development milestones. Download the case study today 👉 https://lnkd.in/g9fr2D7K
Complex challenges call for a nimble approach. And, because every clinical trial looks different, every LabConnect solution looks different. Need to hit an exceedingly tight timeline? Or fast-track custom collection kits? Learn how our nimble approach can help accelerate your drug development milestones. Download the case study today => https://lnkd.in/g9fr2D7K #LabConnect #CaseStudy #ClinicalTrial #Nimble
-
-
Please see below to find out how LabConnect can help to accelerate your drug development timelines.
Complex challenges call for a nimble approach. And, because every clinical trial looks different, every LabConnect solution looks different. Need to hit an exceedingly tight timeline? Or fast-track custom collection kits? Learn how our nimble approach can help accelerate your drug development milestones. Download the case study today => https://lnkd.in/g9fr2D7K #LabConnect #CaseStudy #ClinicalTrial #Nimble
-
-
Efficiency, innovation, and ROI in clinical trials? Yes, you can have it all. Hear how a global pharma leader replaced ValidR with Atorus’ OpenVal®, accelerating innovation and cutting long-term costs. Want to know more about how Atorus drives clinical programming success? Explore the full case study now! https://lnkd.in/gGNmjBuq #clinicaltrials #clinicalprogramming #OpenVal
-
Program Manager, Pharmacovigilance Expert @ PharmaLex | International Service Lead
PharmaLex is thrilled to introduce psiXchange 3.0, our latest intelligent and automated clinical trial safety reporting software 🚀 Discover how psiXchange 3.0 is revolutionizing safety reporting processes, providing intelligent automation and streamlining clinical trial safety reporting like never before. Read more about this groundbreaking innovation: 🔗 https://lnkd.in/gmm8z7xq #Pharmalex #psiXchange #ClinicalTrial #SafetyReporting #Innovation
Cencora PharmaLex Introduces psiXchange 3.0
https://www.pharmalex.com
